Male breast cancer is uncommon, with an occurrence less than 1% that of female breast cancer (1) , resulting in a paucity of identified etiologic predictors. Descriptive studies document that, unlike female breast cancer, there is no plateauing of rates after 50 years of age (and thus relatively late average ages at onset) and a higher incidence in the United States for blacks than whites (2, 3) . Reports of rising incidence of male breast cancer (4, 5) have raised concern, although it is unclear whether changes are real or reflect enhanced detection (6) . Epidemiologic studies of male breast cancer are uncommon, and most to date have been small case-control studies, raising the possibility that identified risk factors could reflect the influence of chance or selection and recall biases.
Similar to female breast cancers, many of the postulated risk factors for male breast cancer suggest the importance of anthropometric and hormonal factors. Notable is a consistent relation between obesity and male breast cancer (7) (8) (9) (10) (11) (12) , with obesity also linked with an increased risk of postmenopausal female breast cancer risk (13) . Studies of male breast cancer in relation to hormonally related medical conditions have shown strong associations with Klinefelter syndrome (14) , a condition characterized by a rare chromosomal abnormality of 47,XXY karyotype and notable hormonal alterations (15) . Male breast cancer has also been associated with gynecomastia (10) , a condition linked with estrogen excesses, as well as less consistently with diabetes (9, 16) , liver cirrhosis (17, 18) , hyperthyroidism (17) , gallstones (17) , and bone fractures (7) . However, the extent to which these associations reflect the influence of concomitant conditions (eg, obesity) remains unresolved.
As with female breast cancer, reproductive history may also be associated with risk; several studies have shown higher risks of male breast cancer with late puberty (16) ; being single, infertile, or childless (8, 10, 11, 16, 17, 19) ; and having undescended testes, testicular trauma, or infections causing orchitis or epididymitis (10, 20, 21) , conditions often associated with gynecomastia.
Several lines of evidence support further pursuit of anthropometric and hormonal factors in the etiology of male breast cancers. However, many exposures of interest have low prevalences, requiring evaluation of associations by data pooling efforts. We therefore conducted a pooled analysis of individual participant data in an international collaboration, the Male Breast Cancer Pooling Project.
Methods

Study Population
For the Male Breast Cancer Pooling Project, we identified all case-control or cohort studies with 10 or more cases of this rare malignancy. Studies were identified from literature searches in PubMed, citations within published manuscripts, and advertisement at the National Cancer Institute Cohort Consortium meetings (http://epi.grants.cancer.gov/Consortia/cohort.html). Although three case-control studies (17, 22, 23) could not contribute because data were no longer available, we secured the contribution of data from 11 case-control (8, 9, 11, 12, 16, 19, (24) (25) (26) (27) (28) and 10 cohort (7, 20, (29) (30) (31) (32) (33) (34) (35) (36) investigations. These studies contributed deidentified data following approved data sharing agreements, as well as National Cancer Institute and study center institutional review board clearances. The case definition was any male breast cancer (International Classification of Diseases, 10th edition: C50; www.cdc.gov/nchs/icd/icd10.htm) reported by a cancer registry, medical record, or self-report. Cancers were required to be incident (ie, diagnosed after exposure ascertainment) for cohort studies and with exposure ascertainment near diagnosis for casecontrol studies. To maximize the number of case patients, we included all male breast cancers, regardless of whether they were diagnosed as a first cancer or not. For cohort studies, we created nested case-control studies with a 40:1 control-to-case ratio using incidence-density matching to retain balance between analytic efficiency and strong statistical power, especially for analyses of less common exposures (37) . Control subjects were matched to case patients on sex (male), race (study-specific categories), study center (for multicenter cohorts), date of birth (±1 year), date of entry (±1 year), and exit date (date last known alive and free of cancer, excluding nonmelanoma skin cancer) greater than or equal to date of diagnosis of case patient. When matching control subjects to male breast cancer case patients that were not first cancers, potential control subjects were not right-censored at diagnosis of cancer, as per the above exit date criterion. Matching for date of entry and of birth was relaxed in increments of ±1 year until ±3 years was reached. We followed these procedures in all but the Kaiser Permanente Multiphasic Health Checkup Cohort (31) , where a 10:1 control-to-case ratio was used. Follow-up ended at date of diagnosis of cancer, death, loss to follow-up, or end of follow-up, whichever occurred first.
Exposures
Exposures harmonized across studies included body mass index (BMI; kg/m 2 ; current/recent [usually obtained at study entry for cohort studies] and at 18-21 and 30-35 years of age), height (cm), weight (kg; current/recent and at 18-21 and 30-35 years of age), Klinefelter syndrome, gynecomastia, diabetes mellitus, osteoporosis, fractures, liver disease, thyroid disease, gallbladder disease, benign prostate disease, cryptorchidism, orchitis, testicular trauma, use of exogenous estrogens/androgens, onset of puberty, ever had children, number of children, and history of infertility. These exposures, usually self-reported, were variously defined. For instance, liver disease in some studies was restricted to cirrhosis, whereas other studies also inquired about liver cysts, hepatitis, or jaundice. Gallbladder disease was usually restricted to information on gallstones. Only a few studies inquired about benign thyroid and prostate diseases, with the information being fairly nonspecific about the types of diseases diagnosed.
Statistical Analysis
To standardize the methods and models for separate pooled analyses of case-control studies and cohort studies (nested case-control studies), we used unconditional logistic regression that adjusted for age (in tertiles based on combined control subjects across studies) and study (categorical) to generate study design-specific odds ratios (ORs) and 95% confidence intervals (CIs). We assessed whether case-control or cohort estimates (betas) deviated by more than 10% when adjusted for education, marital status, race, family history of breast cancer, and status and pack-years of tobacco smoking. None of these factors altered beta coefficients to any appreciable extent. Therefore, the main results presented herein are adjusted only for study and age. The study design-specific odds ratios and 95% confidence intervals were combined using fixed effects metaanalysis to generate overall summary estimates of association (38) . Modeling age as a continuous, instead of categorical, variable did not materially affect the risk estimates. P values for heterogeneity were derived using an interaction term of exposure and study, within each of the pooled analyses of case-control studies and of cohort studies. Additional sensitivity analyses included adjustment for BMI in analyses of gynecomastia, fractures, and Klinefelter syndrome; exclusion of individuals with gynecomastia in analyses of BMI and vice versa; stratification of the main results by median age of diagnosis; reanalysis of all exposures with exclusion of the National Mortality Follow-back Survey (11) because age was age at death rather than at breast cancer diagnosis; and analyses focusing only on male breast cancers occurring as a first primary cancer. All analyses were performed using SAS 9.2 (SAS Institute Inc, Cary, NC) and STATA 11.2 (StataCorp LP, College Station, TX). All statistical tests were two-sided. P values less than .05 were considered statistically significant. results
The study design, study location, and numbers of study subjects for the 21 participating studies are described in Table 1 . A total of 2405 case patients and 52,013 controls subjects were assembled (1190 patients and 4531 control subjects from case-control studies and 1215 patients and 47 482 control subjects from cohort studies). The median age of the case patients was 66.0 years (standard deviation [SD] = 10.8): 64.1 (SD = 11.0) for the case-control studies and 68.0 (SD = 10.2) for the cohort studies. The majority of subjects were white (85.7% overall, 95.8% in the case-control studies, and 84.5% in the cohort studies). The relation of anthropometric variables with male breast cancer risk is shown in Table 2 . Risk increased statistically significantly with adult weight (OR per 5 kg = 1.07; 95% CI = 1.04 to 1.09).
When assessed according to tertiles, those in the highest tertile of weight had an odds ratio of 1.36 (95% CI = 1.18 to 1.57) compared with those in the lowest tertile. The risk associated with weight was more evident in case-control studies than in cohort studies. Height also was statistically significantly positively related to risk (OR = 1.18; 95% CI = 1.01 to 1.38 for the highest vs lowest tertile). When weight and height were simultaneously assessed through the derivation of BMI, men in the highest tertile had an odds ratio of 1.30 (95% CI = 1.12 to 1.51), with somewhat stronger relations observed in case-control studies (OR = 1.39) than cohort studies (OR = 1.16). We also assessed risk in relation to World Health Organization definitions of obesity (http://apps.who.int/bmi/ index.jsp?introPage=intro_3.html). In comparison with healthy weight individuals (BMI = 18.5-24.9 kg/m 2 ), those considered obese (BMI ≥30 kg/m 2 ) showed a risk comparable with that based on a tertile comparison (OR = 1.35; 95% CI = 1.12 to 1.62).
Among a limited number of studies, we also assessed BMI at two earlier age ranges (18-21 and 30-35 years of age). These measures did not appear to predict cancer risk as strongly as BMI ascertained closer to the time of diagnosis, although the estimates for these time periods were less precise given the fewer studies involved.
Evaluation of medical histories in relation to male breast cancer risk revealed statistically significant associations with Klinefelter syndrome (OR = 24.7; 95% CI = 8.94 to 68.4) and gynecomastia (OR = 9.78; 95% CI = 7.52 to 12.70) ( Table 3) . A history of diabetes, assessed in most investigations, was related to a modest but statistically significant risk increase (OR = 1.19; 95% CI = 1.04 to 1.37). Although adult fractures were associated with a slight increase in risk (OR = 1.18; 95% CI = 0.97 to 1.42), based on quite discrepant questions [including skull fractures in one study (26) ], a prior diagnosis of osteoporosis was not associated with any risk elevation (OR = 0.76; 95% CI = 0.45 to 1.28), albeit based on small numbers. Male breast cancer risk was unrelated to a history of liver, thyroid, gallbladder, or prostate diseases from the few studies among which data were available but was associated with a history of cryptorchidism (OR = 2.18; 95% CI = 0.96 to 4.94; based on data only from case-control studies) and orchitis (OR = 1.43; 95% CI = 1.02 to 1.99). Testicular trauma and use of exogenous estrogens/androgens were unrelated to risk, although data were sparse for both exposures.
Although relationships with the aforementioned medical conditions were adjusted only for the effects of study and age, the odds .90
* Odds ratios (ORs) were adjusted for study and age and estimated with unconditional logistic regression. All statistical tests were two-sided. CI = confidence interval. † P values for heterogeneity across individual studies within each category of study (case-control or cohort). NC = not calculable.
ratios were little impacted with further adjustment for BMI. This included little alteration in the risks associated with gynecomastia and diabetes. As an additional means of controlling for BMI, given that obese individuals tend more frequently to have either diabetes or gynecomastia, we examined whether these conditions persisted as risk factors among nonobese individuals. Gynecomastia was statistically significantly related to risk even among men in the lowest BMI tertile. Diabetes was somewhat more strongly related to risk among heavier than thin individuals (OR = 1.16 vs 1.08), but the difference was not statistically significant. The relation between BMI and male breast cancer persisted among those without diabetes or gynecomastia. There was no statistically significant relation between relative age at onset of puberty and risk of male breast cancer (Table 4) . However, a history of never having had children (OR = 1.29; 95% CI = 1.01 to 1.66) was a statistically significant risk factor, with some evidence of lower risks for men with multiple children (OR = 0.94, 95% CI = 0.84 to 1.06 for each child born; OR = 0.65, 95% CI = 0.45 to 0.94 for ≥4 children vs 1 child). These associations persisted when we eliminated subjects with conditions known to result in impaired fertility, such as Klinefelter syndrome. In contrast, a history of infertility, examined only in a few case-control studies, was not statistically significantly related to risk.
We assessed whether there were any substantial differences in the risk factor relations according to whether the age at diagnosis of the male breast cancer was greater or less than the median (66 years) ( Table 5 ). The risk estimates were comparable for most factors, although a history of fractures was a statistically significant risk factor only among the older subjects (OR = 1.41, 95% CI = 1.07 to 1.86; vs OR = 0.99, 95% CI = 0.76 to 1.29 for the younger subjects).
Sensitivity analyses, which separately excluded subjects in the National Mortality Follow-back Survey and male breast cancers that developed only as second cancers, showed little differences in odds ratios as compared with those derived from the full study population.
Discussion
This pooling project provided a unique opportunity to assess risk factors for male breast cancer, a rare disease whose etiology is not well understood. By combining data across the majority of casecontrol studies undertaken for this cancer site and supplementing information from cases that had developed within numerous cohort investigations, we confirmed that male breast cancer is associated with a number of anthropometric and hormonally related factors. With a large number of events, we were able to disentangle effects of correlated risk factors (eg, medical conditions linked with obesity) and examine more conclusively some reproductive factors that may reflect hormonal alterations.
Similar to other investigations (21,39), we found that patients with Klinefelter syndrome were at a very high risk of male breast cancer. Although the extra X chromosome that defines this syndrome has been extensively discussed as a basis for the elevated cancer risk, associated hormonal explanations remain unclear. It is of particular interest that such patients have low levels of testosterone and high levels of estrogens (15), resulting in a high estrogen/androgen ratio. This has been hypothesized to lead to abnormal hormonal stimulation of cell proliferation of the mammary ductal epithelium (40) .
The association for obesity observed in men was of interest given a similar recognized pattern for female postmenopausal breast cancer. In fact, the approximate 30% increased risk we observed in men is nearly identical to that for postmenopausal breast cancer risk (13) . We observed a stronger relation of BMI (and especially weight) in the case-control studies than the cohort studies. This could reflect selection biases in the case-control studies (eg, thinner control subjects being willing to be interviewed). Alternatively, the difference could result from case-control studies focusing on more recent measures of obesity because anthropometric measures in cohort studies usually derived from the time of cohort establishment. Of note is that a stronger influence of contemporary weight has been observed for female breast cancer (13) . In women, the association between obesity and postmenopausal breast cancer risk may be mediated, in part, by the peripheral conversion of androgens to estrogens (41) , which are clearly linked with risk elevations (42) . In men, obesity is associated with high estrogen levels as well as low testosterone and sex hormone binding globulin (43, 44) levels, leading to greater estrogen bioavailability.
Klinefelter patients often have gynecomastia, another recognized risk factor for male breast cancer that was confirmed in this study. Although gynecomastia is associated with the detection of male breast cancer (45, 46) , its relevance as an etiologic factor has been questioned (47) . It has been postulated that it might affect risk through providing increased tissue at risk, but it is also possible that increased surveillance, recall biases, or uncontrolled confounding for other risk predictors could be involved. However, our findings suggested that the association of gynecomastia appeared independent from that of BMI.
We also assessed several other medical conditions that have not been definitively linked with male breast cancer. We found slightly elevated risks associated with a history of diabetes. Although this could reflect residual confounding by obesity, particularly because the relation was strongest among obese individuals and our obesity measure was limited to recent BMI, low testosterone levels have been reported among male diabetics (48)-possibly supporting a biological explanation. Results from other studies have also raised interest in possible relations with liver cirrhosis (17, 18) , given excessive production of estrogens and a reduction in circulating free testosterone due to elevated sex steroid hormone binding globulin. Furthermore, cholelithiasis has been postulated as a potential risk factor (17) because estrogens increase biliary cholesterol secretion that can result in cholesterol supersaturation of bile ducts and the formation of stones (49) . However, we failed to observe risk relations with either liver or thyroid diseases, including hyperthyroidism, which has been related to risk in one previous investigation (17) .
Other hormonally related medical conditions include osteoporosis and bone fractures, which have been shown to be inversely related to female breast cancers, presumably because of low estrogen levels (50) . Both estrogen and testosterone are important for bone maintenance in men (51); thus, decreasing levels of bioavailable testosterone with age (52) could lead to alterations in the bioavailable ratio of estrogen to testosterone and increases in male breast cancer (40) . We found no relation of either osteoporosis or fractures with male breast cancer; however, there was some evidence that fractures might predispose to male breast cancers occurring at older ages. Although possibly reflecting greater surveillance, the relation of fractures at older ages to increased male breast cancer risk would be consistent with an effect of an increasing ratio of estrogens to androgens with age. However, it is possible that other hormones could be involved, including prolactin, given that male breast cancers have been associated with skull fractures and other head trauma, established risk factors for prolactinomas (26) . Although female breast cancer is recognized as being associated with a variety of reproductive factors (eg, parity and age at first birth), little attention has focused on reproductive factors related to male breast cancer. We found no evidence for an association of age at puberty with male breast cancer risk, but men who had never had children were at a significantly elevated risk. Although this was not supported by an association with infertility, relatively few studies had information on this parameter. Moreover, older men may not have been evaluated for infertility, and even when tested, the reasons for infertility in men can be quite varied. It is also possible that socioeconomic and lifestyle factors could have contributed to the relation with parity.
The major strength of this analysis is the large number of male breast cancers studied. However, as with most pooling projects, one of the major limitations is the availability of exposure data across all studies, sometimes leading to small numbers for a specific exposure. The manner in which some of the questions were asked varied across studies, which could have impacted the results. We were also unable to stratify results by BRCA status, a major predictor of male breast cancer, nor did we have information on clinical characteristics of the tumors; however, based upon other studies (53), we can assume that most tumors were estrogen receptor positive.
In this pooled analysis, we identified statistically significant associations of male breast cancer with a number of anthropometric and hormonally related risk factors, including BMI and various medical and reproductive parameters. Many of these risk factors support the need for exploring the role of endogenous hormones, which will be assessed in future analyses using samples from our cohort investigations. * Pertained to age at death for one study, the National Mortality Follow-back Survey. † Odds ratios (ORs) were adjusted for study and age and estimated with unconditional logistic regression. All statistical tests were two-sided. CI = confidence interval.
Downloaded from https://academic.oup.com/jnci/article-abstract/106/3/djt465/986640 by guest on 15 March 2019
Cancer for funding and also thank the men who participated in the study, the consultants under whose care they were, the cancer registries, and colleagues who worked on and advised the study.
Funding
